First Trust Nasdaq Pharmaceuticals ETF (FTXH) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free FTXH Stock Alerts $27.01 +0.21 (+0.78%) (As of 11:17 AM ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media First Trust Nasdaq Pharmaceuticals ETF Short Interest DataCurrent Short Volume1,000 sharesPrevious Short Volume3,000 sharesChange Vs. Previous Month-66.67%Dollar Volume Sold Short$27,800.30Short Interest Ratio / Days to Cover0.1Last Record DateFebruary 15, 2024Outstanding Shares750,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume338 sharesAverage Trading Volume6,465 sharesToday's Volume Vs. Average5% Short Selling First Trust Nasdaq Pharmaceuticals ETF ? Sign up to receive the latest short interest report for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFTXH Short Interest Over TimeFTXH Days to Cover Over TimeFTXH Percentage of Float Shorted Over Time Ad InvestorPlaceDoes this chart look familiar?Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. First Trust Nasdaq Pharmaceuticals ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/20241,000 shares $27,800.30 -66.7%N/A0.1 $27.80 1/31/20243,000 shares $80,910.00 -44.4%N/A0.4 $26.97 1/15/20245,400 shares $147,366.00 +500.0%N/A0.7 $27.29 12/31/2023900 shares $23,953.50 -35.7%N/A0.1 $26.62 12/15/20231,400 shares $36,652.00 +1,300.0%N/A0.2 $26.18 11/30/2023100 shares $2,498.00 -66.7%N/A0 $24.98 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11/15/2023300 shares $7,368.00 +200.0%N/A0 $24.56 10/31/2023100 shares $2,404.00 -66.7%N/A0 $24.04 10/15/2023300 shares $7,683.00 +50.0%N/A0 $25.61 9/30/2023200 shares $5,113.52 -89.5%N/A0 $25.57 9/15/20231,900 shares $50,160.00 -77.1%N/A0.2 $26.40 8/31/20238,300 shares $223,021.00 +8,200.0%N/A0.6 $26.87 8/15/2023100 shares $2,705.00 -66.7%N/A0 $27.05 7/31/2023300 shares $7,960.89 -66.7%N/A0 $26.54 7/15/2023900 shares $23,418.00 -76.3%N/A0.1 $26.02 6/30/20233,800 shares $99,522.00 -28.3%N/A0.3 $26.19 6/15/20235,300 shares $140,821.00 -15.9%N/A0.6 $26.57 5/31/20236,300 shares $161,028.00 +6,200.0%N/A0.5 $25.56 5/15/2023100 shares $2,662.00 -66.7%N/A0 $26.62 4/30/2023300 shares $7,979.88 -25.0%N/A0 $26.60 4/15/2023400 shares $10,760.00 -20.0%N/A0 $26.90 3/31/2023500 shares $13,049.20 +400.0%N/A0 $26.10 3/15/2023100 shares $2,552.87 -99.0%N/A0 $25.53 2/28/20239,500 shares $249,850.00 -65.5%N/A0.7 $26.30 2/15/202327,500 shares $749,289.75 +19.6%N/A2.4 $27.25 1/31/202323,000 shares $633,190.00 -9.1%N/A2.1 $27.53 1/15/202325,300 shares $707,663.77 +94.6%N/A2.1 $27.97 12/30/202213,000 shares $356,590.00 -41.2%N/A0.9 $27.43 12/15/202222,100 shares $612,612.00 -29.2%N/A1.7 $27.72 11/30/202231,200 shares $874,536.00 +339.4%N/A2.4 $28.03 11/15/20227,100 shares $190,990.00 +153.6%N/A0.6 $26.90 10/31/20222,800 shares $74,032.00 +64.7%N/A0.2 $26.44 10/15/20221,700 shares $41,752.00 No ChangeN/A0.1 $24.56 9/30/20223,700 shares $88,948.00 -28.9%N/A0.2 $24.04 9/15/20225,200 shares $130,052.00 -27.8%N/A0.1 $25.01 8/31/20227,200 shares $179,136.00 -56.9%N/A0.1 $24.88 8/15/202216,700 shares $445,222.00 +18.4%N/A0.3 $26.66 7/31/202214,100 shares $373,509.00 +93.2%N/A0.3 $26.49 7/15/20227,300 shares $194,764.00 No ChangeN/A0.2 $26.68 2/15/20226,100 shares $156,831.00 -10.3%N/A2 $25.71Does this chart look familiar? (Ad)Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. FTXH Short Interest - Frequently Asked Questions What is First Trust Nasdaq Pharmaceuticals ETF's current short interest? Short interest is the volume of First Trust Nasdaq Pharmaceuticals ETF shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 1,000 shares of FTXH short. Learn More on First Trust Nasdaq Pharmaceuticals ETF's current short interest. Is First Trust Nasdaq Pharmaceuticals ETF's short interest increasing or decreasing? First Trust Nasdaq Pharmaceuticals ETF saw a decline in short interest in February. As of February 15th, there was short interest totaling 1,000 shares, a decline of 66.7% from the previous total of 3,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does First Trust Nasdaq Pharmaceuticals ETF's short interest compare to its competitors? Here is how the short interest of companies compare to First Trust Nasdaq Pharmaceuticals ETF: Invesco Nasdaq Biotechnology ETF (1.30%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (8.82%), Principal Healthcare Innovators ETF (0.36%), ProShares Ultra Nasdaq Biotechnology (0.99%), Invesco S&P SmallCap Health Care ETF (0.03%), VanEck Biotech ETF (0.08%), VanEck Pharmaceutical ETF (24.24%), and iShares Biotechnology ETF (16.44%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short First Trust Nasdaq Pharmaceuticals ETF stock? Short selling FTXH is an investing strategy that aims to generate trading profit from First Trust Nasdaq Pharmaceuticals ETF as its price is falling. FTXH shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against First Trust Nasdaq Pharmaceuticals ETF? A short squeeze for First Trust Nasdaq Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FTXH, which in turn drives the price of the stock up even further. How often is First Trust Nasdaq Pharmaceuticals ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTXH, twice per month. The most recent reporting period available is February, 15 2024. More Short Interest Resources from MarketBeat Related Companies: IBBQ Short Squeeze JDOC Short Squeeze BIS Short Squeeze BTEC Short Squeeze BIB Short Squeeze PSCH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FTXH) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorNext President (Not Trump. Not Biden.)The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & Company